Dabur India expects 10%+ consolidated growth in Q1 FY24

However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.

Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr

The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022

Dabur India expects low to mid-single digit revenue growth for Q3 FY23

International Business is expected to post double-digit revenue growth during the quarter in constant currency.

Dabur India posts consolidated Q2 FY2023 PAT at Rs. 490.06 Cr

The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022

Dabur launches 'Dabur Himalayan Shilajit'

Sanofi Consumer Healthcare India appoints Himanshu Bakshi as MD

Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles

CCRAS hosts national consultative meet on traditional medicine

Signs MoUs with Shri Krishna Ayush University and Dabur India

Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business

His most recent stint was with Danone India as its Managing Director

Piramal Critical Care appoints Jeffrey Hampton as President & COO

Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal